[HTML][HTML] Contrast-enhanced mammography versus breast magnetic resonance imaging: a systematic review and meta-analysis
Background: Contrast-enhanced mammography (CEM) and contrast-enhanced magnetic
resonance imaging (CE-MRI) are commonly used in the screening of breast cancer. The …
resonance imaging (CE-MRI) are commonly used in the screening of breast cancer. The …
[HTML][HTML] Impact of imaging biomarkers and AI on breast cancer management: A brief review
Simple Summary Artificial intelligence (AI) has seamlessly integrated into the medical field,
especially in diagnostic imaging, thanks to ongoing AI advancements. It is widely used in …
especially in diagnostic imaging, thanks to ongoing AI advancements. It is widely used in …
[HTML][HTML] Contrast enhanced mammography: focus on frequently encountered benign and malignant diagnoses
ML Yang, C Bhimani, R Roth, P Germaine - Cancer Imaging, 2023 - Springer
Contrast-enhanced mammography (CEM) is becoming a widely adopted modality in breast
imaging over the past few decades and exponentially so over the last few years, with strong …
imaging over the past few decades and exponentially so over the last few years, with strong …
[HTML][HTML] AI-based cancer detection model for contrast-enhanced mammography
C Jailin, S Mohamed, R Iordache… - Bioengineering, 2023 - mdpi.com
Background: The recent development of deep neural network models for the analysis of
breast images has been a breakthrough in computer-aided diagnostics (CAD). Contrast …
breast images has been a breakthrough in computer-aided diagnostics (CAD). Contrast …
Contrast-enhanced mammography implementation, performance, and use for supplemental breast cancer screening
MF Covington - Radiologic Clinics, 2021 - radiologic.theclinics.com
Contrast-enhanced mammography (CEM) remains an emerging technology despite being
approved by the Food and Drug Administration (FDA) for clinical use since 2011. Over …
approved by the Food and Drug Administration (FDA) for clinical use since 2011. Over …
[HTML][HTML] Assessment of nanoparticle-mediated tumor oxygen modulation by photoacoustic imaging
M Sivasubramanian, LW Lo - Biosensors, 2022 - mdpi.com
Photoacoustic imaging (PAI) is an invaluable tool in biomedical imaging, as it provides
anatomical and functional information in real time. Its ability to image at clinically relevant …
anatomical and functional information in real time. Its ability to image at clinically relevant …
Investigation of test methods for QC in dual-energy based contrast-enhanced digital mammography systems: I. Iodine signal testing
L Cockmartin, H Bosmans… - Physics in Medicine & …, 2023 - iopscience.iop.org
The technique of dual-energy contrast enhanced mammography (CEM) visualizes iodine
uptake in cancerous breast lesions following an intravenous injection of a contrast medium …
uptake in cancerous breast lesions following an intravenous injection of a contrast medium …
State-of-the-art for contrast-enhanced mammography
MF Covington, S Salmon, BD Weaver… - British Journal of …, 2024 - academic.oup.com
Contrast-enhanced mammography (CEM) is an emerging breast imaging technology with
promise for breast cancer screening, diagnosis, and procedural guidance. However, best …
promise for breast cancer screening, diagnosis, and procedural guidance. However, best …
Contrast-enhanced mammography: a guide to setting up a new clinical program
G Kim, B Patel, TS Mehta, L Du… - Journal of Breast …, 2021 - academic.oup.com
Contrast-enhanced mammography (CEM) is gaining rapid traction following the US Food
and Drug Administration approval for diagnostic indications. Contrast-enhanced …
and Drug Administration approval for diagnostic indications. Contrast-enhanced …
Accuracy of contrast-enhanced spectral mammography compared with MRI for invasive breast cancers: prospective study in population of predominantly …
Objectives This prospective study compares contrast-enhanced spectral mammography
(CESM) with contrast-enhanced breast MRI in assessing the extent of newly diagnosed …
(CESM) with contrast-enhanced breast MRI in assessing the extent of newly diagnosed …